Works matching IS 13520504 AND DT 2019 AND VI 26

Results: 202
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016‐2017.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1377, doi. 10.1111/jvh.13184
    By:
    • Maisa, Anna;
    • Semple, Susan;
    • Griffiths, Alison;
    • Ngui, Siew Lin;
    • Verlander, Neville Q.;
    • McCaughey, Conall;
    • Doherty, Lorraine;
    • Jessop, Lucy;
    • Quinn, Briege;
    • Ewing, Judith;
    • Creasy, Victoria;
    • Owen, Michael;
    • McKeown, Gary;
    • Armstrong, Gillian;
    • Chada, Naresh;
    • Patterson, Karen;
    • McGall, Jan;
    • Toal, Helen;
    • Wasson, Gemma;
    • McDougall, Neil
    Publication type:
    Article
    14
    15
    16
    17
    18

    Issue Information.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1359, doi. 10.1111/jvh.12961
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26

    The ECHO model proved to be a useful tool to increase clinicians' self‐effectiveness for care of patients with Hepatitis C in Argentina.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 11, p. 1284, doi. 10.1111/jvh.13172
    By:
    • Mendizabal, Manuel;
    • Ridruejo, Ezequiel;
    • Ceballos, Susana;
    • Sixto, Marcela;
    • Billordo, Ariel;
    • Gadea, Claudia;
    • Mengarelli, Silvia;
    • Alonso, Cristina;
    • Palazzo, Ana;
    • De María, Luis;
    • Bruno, Andrés;
    • Perez, Daniela;
    • Piñero, Federico;
    • Deltrozzo, Verónica;
    • Mendoza, Carlos;
    • Figueroa, Sebastián;
    • Manero, Estela;
    • Villa, Marina;
    • Barreyro, Fernando;
    • Moreno, Valeria
    Publication type:
    Article
    27
    28

    Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 11, p. 1266, doi. 10.1111/jvh.13170
    By:
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Atsukawa, Masanori;
    • Toyoda, Hidenori;
    • Takaguchi, Koichi;
    • Nakamuta, Makoto;
    • Matsumoto, Nobuyuki;
    • Okuse, Chiaki;
    • Tada, Toshifumi;
    • Tsutsui, Akemi;
    • Yamashita, Naoki;
    • Kondo, Chisa;
    • Hayama, Korenobu;
    • Kato, Keizo;
    • Itokawa, Norio;
    • Arai, Taeang;
    • Shimada, Noritomo;
    • Asano, Toru;
    • Uojima, Haruki;
    • Ogawa, Chikara
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Issue Information.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 11, p. 1237, doi. 10.1111/jvh.12960
    Publication type:
    Article
    35

    Cover Image.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. i, doi. 10.1111/jvh.13198
    By:
    • Ning, Qin;
    • Wu, Di;
    • Wang, Gui-Qiang;
    • Ren, Hong;
    • Gao, Zhi-Liang;
    • Hu, Peng;
    • Han, Mei-Fang;
    • Wang, Yan;
    • Zhang, Wen-Hong;
    • Lu, Feng-Min;
    • Wang, Fu‐Sheng
    Publication type:
    Article
    36
    37

    Hepatitis E virus prevalence in Flemish blood donors.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1218, doi. 10.1111/jvh.13161
    By:
    • Vercouter, Ann‐Sofie;
    • Van Houtte, Freya;
    • Verhoye, Lieven;
    • González Fraile, Isabel;
    • Blanco, Lydia;
    • Compernolle, Veerle;
    • Meuleman, Philip
    Publication type:
    Article
    38

    Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1229, doi. 10.1111/jvh.13159
    By:
    • Asselah, Tarik;
    • Shafran, Stephen D.;
    • Bourgeois, Stefan;
    • Lai, Ching‐Lung;
    • Mathurin, Philippe;
    • Willems, Bernard;
    • Nguyen, Mindie H.;
    • Davis, Mitchell N.;
    • Huang, K. C.;
    • Svarovskaia, Evguenia;
    • Osinusi, Anu;
    • McNally, John;
    • Brainard, Diana M.;
    • Shaikh, Obaid S.;
    • Tran, Tram T.
    Publication type:
    Article
    39
    40
    41
    42

    B.A.R.C.O.S. (Brazilian Argentine Hepatitis C Collaborative Observational Study): Effectiveness and clinical outcomes of HCV treatment with daclatasvir and sofosbuvir with or without ribavirin.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1200, doi. 10.1111/jvh.13148
    By:
    • Ridruejo, Ezequiel;
    • Cheinquer, Hugo;
    • Marciano, Sebastián;
    • Mendizabal, Manuel;
    • Piñero, Federico;
    • Wolff, Fernando H.;
    • Araujo, Alexandre;
    • Coelho Borges, Silvia;
    • Kliemann, Dimas;
    • Fleck, Alfeu;
    • de Maman, Ítalo;
    • Nader, Lysandro A.;
    • Garrastazul, Patricia;
    • Bermúdez, Carla;
    • Haddad, Leila;
    • Gadano, Adrián;
    • Silva, Marcelo
    Publication type:
    Article
    43
    44

    Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1224, doi. 10.1111/jvh.13146
    By:
    • Willemse, Sophie;
    • Smit, Colette;
    • Sogni, Philippe;
    • Sarcletti, Mario;
    • Uberti‐Foppa, Caterina;
    • Wittkop, Linda;
    • Raben, Dorthe;
    • D'Arminio Monforte, Antonella;
    • Dabis, Francois;
    • Van Der Valk, Marc;
    • Judd, Ali;
    • Zangerle, Robert;
    • Touloumi, Giota;
    • Warszawski, Josiane;
    • Meyer, Laurence;
    • Dabis, François;
    • Murielle Mary Krause;
    • Ghosn, Jade;
    • Leport, Catherine;
    • Reiss, Peter
    Publication type:
    Article
    45
    46
    47
    48

    Issue Information.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1143, doi. 10.1111/jvh.12959
    Publication type:
    Article
    49

    Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1127, doi. 10.1111/jvh.13132
    By:
    • Lawitz, Eric;
    • Gane, Edward;
    • Feld, Jordan J.;
    • Buti, Maria;
    • Foster, Graham R.;
    • Rabinovitz, Mordechai;
    • Burnevich, Eduard;
    • Katchman, Helena;
    • Tomasiewicz, Krzysztof;
    • Lahser, Fred;
    • Jackson, Beth;
    • Shaughnessy, Melissa;
    • Klopfer, Stephanie;
    • Yeh, Wendy W.;
    • Robertson, Michael N.;
    • Hanna, George J.;
    • Barr, Eliav;
    • Platt, Heather L.;
    • Gordon, Stuart C.;
    • Lawitz, Eric J.
    Publication type:
    Article
    50